[微波除治疗肺癌的免疫机制的进展]
Zhenyu Yang1, Xiaowen Chen1, Junhong Jiang1
1Department of Respiratory and Critical Care Medicine, The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital), Suzhou 215000, China.
Zhongguo fei ai za zhi = Chinese journal of lung cancer
|February 2, 2026
概括
微波除 (MWA) 通过诱导细胞死亡和激活抗瘤免疫力,有效治疗肺癌. 将MWA与免疫药物结合使用可能为改善肺癌治疗策略提供协同效应.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 最少侵入性的手术
背景情况:
- 微波除 (MWA) 是一种用于肺癌治疗的微创热除技术.
- MWA诱导局部瘤细胞亡,并调节瘤免疫微环境 (TIME).
研究的目的:
- 审查MWA激活肺癌中抗瘤免疫反应的机制.
- 为未来结合MWA和免疫治疗的肺癌治疗策略提供理论基础.
主要方法:
- 对MWA和肺癌中的抗瘤免疫研究的文献综述.
- 分析MWA对瘤免疫微环境和远程免疫效应的影响.
主要成果:
- MWA有效地诱导瘤细胞死亡.
- MWA调节瘤免疫微环境,激活抗瘤免疫反应.
- 当将MWA与抗瘤免疫药物结合使用时,存在潜在的协同效应.
结论:
- MWA是一种有前途的肺癌治疗方法,不仅局部,而且通过刺激全身抗瘤免疫力.
- 对肺癌患者来说,MWA和免疫疗法的联合治疗提供了一个新的治疗方向.
相关概念视频
Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
mTOR Signaling and Cancer Progression
4.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.8K
Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
Adaptive Mechanisms in Cancer Cells
7.1K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.1K
Mechanisms of Retrovirus-induced Cancers
7.0K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.0K


